Home > Financial Ratios > OXYGENTA PHARMACEUTICAL

OXYGENTA PHARMACEUTICAL
EV/Core EBITDA

    Back to All Ratios
OXYGENTA PHARMACEUTICAL is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for OXYGENTA PHARMACEUTICAL
Please provide your vote to see the results

OXYGENTA PHARMACEUTICAL Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) -42.25-15.97-16.8858.1714.65

What is the latest EV/Core EBITDA ratio of OXYGENTA PHARMACEUTICAL ?

The latest EV/Core EBITDA ratio of OXYGENTA PHARMACEUTICAL is -42.25 based on Mar2025 Standalone results.
Year EV/Core EBITDA
Mar2025-42.25
Mar2024-15.97
Mar2023-16.88
Mar202258.17
Mar202114.65

How is EV/Core EBITDA of OXYGENTA PHARMACEUTICAL Trending?

Years EV/Core EBITDA % Change
Mar2025 -42.25
Negative
Mar2024 -15.97
Negative
Mar2023 -16.88
Negative
Mar2022 58.17
297.06
Mar2021 14.65 -

Other Financial Ratios of OXYGENTA PHARMACEUTICAL


Compare EV/Core EBITDA ratio of peers of OXYGENTA PHARMACEUTICAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL ₹198.1 Cr -0.8% -14.1% -38.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹414,929.0 Cr 0.7% -4.2% -8.7% Stock Analytics
DIVIS LABORATORIES ₹169,644.0 Cr 0% -1% 4% Stock Analytics
TORRENT PHARMACEUTICALS ₹131,481.0 Cr 2.4% 4.5% 14.5% Stock Analytics
CIPLA ₹122,050.0 Cr 1.1% 0.2% -1.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,784.0 Cr -1% -2% -9.7% Stock Analytics


OXYGENTA PHARMACEUTICAL Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL

-0.8%

-14.1%

-38.7%

SENSEX

0.9%

0.7%

9.6%


You may also like the below Video Courses